Research Associate - Cancer Center - 140757
UC San Diego | |
$68,466 - $110,142
| |
United States, California, San Diego | |
Aug 10, 2026 | |
|
UCSD Layoff from Career Appointment: Apply by 8/12/26 for consideration with preference for rehire. All layoff applicants should contact their Employment Advisor. Reassignment Applicants: Eligible Reassignment clients should contact their Disability Counselor for assistance. The Moores Cancer Center (MCC) is one of just 57 NCI-designated Comprehensive Cancer Centers in the United States and the only one in San Diego County. As a consortium cancer center, it is a collaborative partnership between the UCSD: encompassing 28 departments, 6 schools (School of Medicine, Skaggs School of Pharmacy and Pharmaceutical Sciences, School of Public Health, Jacobs School of Engineering, School of Biological Sciences & the School of Physical Sciences), UCSD Health oncology hospitals and clinics; the basic and public health research and outreach of San Diego State University (SDSU), and the basic and translational research of the La Jolla Institute of Immunology (LJI). These various programs and units are all dedicated to fulfilling the Moores Cancer Center's mission of reducing cancer's burden. As such, it ranks among the top centers in the nation conducting the continuum of cancer research, providing advanced patient care, and serving the community through outreach and education programs. As a top-ranking, future-oriented organization, we offer challenging career opportunities in a fast-paced and innovative environment. Moores Cancer Center follows a progressive philosophy of career-path development for its employees including opportunities for cross-training, professional development, and progressive responsibility. MCC's mission is to transform cancer care in our catchment area and beyond by driving exceptional scientific discoveries and innovations in prevention, detection, care, and training. MCC will make a global impact on improving health by reducing cancer burden through accelerated discovery and translation, compassionate and interdisciplinary care, education and community engagement, with the foundation of our core values - Excellence, Innovation and Risk-Taking, Collaboration, Diversity and Service. Under the supervision of a Principal Investigator, the incumbent will apply a wide variety of experimental research techniques to problems of cell growth and oncogenic transformation related to gastrointestinal cancer. Collaborate with PI on methods to the investigation cell signaling and their respective roles in processes associated with tumor progression. Additionally, the incumbent will provide bioinformatics, statistical, data management and report support for computational analyses and lab research with primary analysis focus in multi-omic analyses. Perform advanced data analysis and statistical methodologies based on integrative approaches including, e.g., genomic, proteomic, clinical and other types of data. Independently perform routine laboratory experiments, such as immunoblotting, cell viability assays, confocal microscopy, Real-Time PCR analyses and immunofluorescence, cell cycle analysis of in-vitro cell lines. Independently work on data preparation for large scale data analysis and provide support for manuscript publication. MINIMUM QUALIFICATIONS
Pay Transparency Act Annual Full Pay Range: $68,466 - $110,142 (will be prorated if the appointment percentage is less than 100%) Hourly Equivalent: $32.79 - $52.75 Factors in determining the appropriate compensation for a role include experience, skills, knowledge, abilities, education, licensure and certifications, and other business and organizational needs. The Hiring Pay Scale referenced in the job posting is the budgeted salary or hourly range that the University reasonably expects to pay for this position. The Annual Full Pay Range may be broader than what the University anticipates to pay for this position, based on internal equity, budget, and collective bargaining agreements (when applicable). | |
$68,466 - $110,142
Aug 10, 2026